Company profile: Chiva Pharmaceuticals
1.1 - Company Overview
Company description
- Provider of global pharmaceutical solutions focused on bringing the best standard of care to the Chinese market and making drugs developed in China available worldwide.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Chiva Pharmaceuticals
Schwarz Pharma
HQ: Germany
Website
- Description: Provider of pharmaceutical product development, bringing approved and late-stage new compounds with complementary therapeutic and geographic focus, supported by strong talent and cultural fit.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Schwarz Pharma company profile →
Corridor Pharmaceuticals
HQ: United States
Website
- Description: Provider of platform-based pulmonary and critical care therapeutics, developing and commercializing small-molecule inhibitors of arginase to address elevated arginase levels, targeting arginase—an enzyme that competes with endothelial nitric oxide synthase for l-arginine and leads to ornithine production.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Corridor Pharmaceuticals company profile →
Lin Bioscience
HQ: Taiwan
Website
- Description: Provider of innovative drug therapies addressing unmet medical needs, developing: LBS-008, an oral treatment for dry age-related macular degeneration and Stargardt disease; LBS-007, a CDC7 inhibitor for leukemia and solid tumors; LBS-002, an anti-tubulin therapy for brain tumors that crosses the blood-brain barrier; and LBS-009, an oral therapy for NAFLD and type 2 diabetes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lin Bioscience company profile →
Sirona Biochem
HQ: Canada
Website
- Description: Provider of biotechnology solutions including diabetes therapeutics, cosmetic skin depigmenting and anti-aging agents, biological ingredients and cancer vaccine antigens. Offers compounds such as TFC-1067, LIP-01 and SGLT2 inhibitors, enabled by GlycoMim technology and fluorination chemistry to stabilize carbohydrate-based molecules and enhance pharmaceutical and cosmetic properties.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sirona Biochem company profile →
InnoPharma
HQ: United States
Website
- Description: Provider of niche-generic, specialty pharmaceutical and bio-pharmaceutical product development, operating as a privately held pharmaceutical R&D company founded in 2005 and based in Piscataway, New Jersey.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InnoPharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Chiva Pharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Chiva Pharmaceuticals
2.2 - Growth funds investing in similar companies to Chiva Pharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Chiva Pharmaceuticals
4.2 - Public trading comparable groups for Chiva Pharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →